AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

YELLOW FEVER VACCINE (Subcutaneous route, Injection route) - YEL-loe FEE-ver vak-SEEN.(Drug overview)

USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language

| May 01, 2007 | COPYRIGHT 1996 USP DIĀ® and Advice for the PatientĀ® are registered trademarks of USP used under license to Micromedex, Inc. (Hide copyright information)Copyright

Brand names in the United States --

* Yf-Vax

Dosage forms --

* Powder for Suspension

* Powder for Solution

* Injectable

Therapeutic classification: Vaccine

DESCRIPTION OF USE

Yellow Fever Vaccine is used to prevent infection by the yellow fever virus. It works by causing your body to produce its own protection (antibodies) against the virus.

Vaccination against yellow fever is recommended for all persons 9 months of age and older who are traveling to or living in areas of Africa, South America, or other countries where there is yellow fever infection and for people who are traveling to countries that require yellow fever immunization (certificate of vaccination). It is also needed by other people who might come into contact with the yellow fever virus.

Infants 6 to 9 months of age and pregnant women should be vaccinated only if they must travel to areas where there is an epidemic of yellow fever and they cannot be protected from mosquito bites.

Infants 4 to 6 months of age may be vaccinated only if there is a high risk of getting yellow fever infection.

Vaccination against yellow fever is not recommended for infants younger than 4 months of age because they have an …

Related articles from newspapers, magazines, journals, and more
Yellow Fever Vaccine (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language August 1, 2006 700+ words
Yellow Fever Vaccine (Systemic).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2006 700+ words
Yellow fever vaccine (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language January 1, 1996 700+ words
Xcellerex initiates Phase I clinical trial of novel yellow fever vaccine.
News wire article from: Chemical Business Newsbase January 12, 2010 700+ words
Ministry runs out of yellow fever vaccine.
News wire article from: Asia Africa Intelligence Wire February 5, 2005 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily